Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Celldex Therapeutics, Inc. (CLDX) Debt to Capital Ratio data is not available for the most recently reported fiscal year, ending 2023-12-31.
Income Statement Financials | |
$6.88M |
|
$-141.43M |
|
-- |
|
$6.88M |
|
$161.43M |
|
$-154.54M |
|
$13.11M |
|
$-141.43M |
|
$-141.43M |
|
$-141.43M |
|
$-141.43M |
|
$-141.43M |
|
$-141.43M |
|
$-154.54M |
|
$-157.76M |
|
48.45M |
|
48.45M |
|
$-2.92 |
|
$-2.92 |
|
Balance Sheet Financials | |
$431.69M |
|
$4.06M |
|
$33.93M |
|
$465.63M |
|
$31.12M |
|
-- |
|
$5.33M |
|
$36.46M |
|
$429.17M |
|
$401.98M |
|
$429.17M |
|
55.88M |
|
Cash Flow Statement Financials | |
$-107.29M |
|
$-105.78M |
|
$218.46M |
|
$29.43M |
|
$34.81M |
|
$5.38M |
|
$23.89M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
13.87 |
|
-- |
|
-- |
|
Debt to Capital Ratio |
-- |
-- |
|
100.00% |
|
-2245.27% |
|
-2245.27% |
|
-2291.97% |
|
-2054.76% |
|
-2054.76% |
|
$-109.11M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
2.62 |
|
139.36 |
|
-32.95% |
|
-35.18% |
|
-30.37% |
|
-32.95% |
|
$7.68 |
|
$-2.25 |
|
$-2.21 |